The World Health Organization (WHO) prepared the document “Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021−2030” (“the road map”) through an extensive global consultation pursuant to decision EB146(9) of the Executive Board at its 146th session, which culminated in the endorsement of the document by the Seventy-third World Health Assembly in 2020. The road map sets global targets and milestones to prevent, control, eliminate or eradicate 20 diseases and disease groups as well as cross-cutting targets aligned with the Sustainable Development Goals. These include overarching, cross-cutting and disease-specific targets the achievement of which requires considerable work by countries and stakeholders.
The WHO Secretariat is leading the follow-up assessment of four of the eleven dimensions of the heat map by using a gap assessment tool (GAT), a qualitative, participatory device for tracking progress towards the 2030 targets of the road map. This public consultation seeks your perceptions on the status of progress along these four dimensions for all 20 NTDs. Your inputs will be consolidated for consideration by disease-specific focus groups whose deliberations will identify current gaps that pose a persistent risk to the attainment of the road map targets. This will provide qualitative evidence on corrective measures needed to address these gaps and inform reporting on global progress against NTDs to the Seventy-sixth World Health Assembly in 2024.
WHO is inviting you to participate in this second public consultation by completing the online questionnaire in this phase of web consultation. It is also available in from the questionnaire itself in Arabic, French, Spanish and Portuguese. You will be able to select the diseases and dimensions for which you would like to provide response.
Read moreGavi is currently recruiting three consultant positions to support Gavi’s next Vaccine Investment Strategy (VIS). The VIS is Gavi’s evidence-informed process that takes place every 5 years to evaluate the full value of new vaccines (or underused ones) in support of Gavi’s Board investment decisions. Selected vaccines would then be included into Gavi’s portfolio at the next strategic period (2026-2030). The consultant roles are one-year roles with possibility of extension. Candidates are sought with experience in public health, epidemiology, health economics, impact modelling or closely related field and with strong quantitative and qualitative analysis skills. In particular, the consultant positions are a great opportunity for researchers with an interest in policy analysis and investment case development to get exposure to how policy and investment decisions are made, including engagement with numerous stakeholders.
The following consultants are being recruited:
1 x Senior manager (L4)
2 x Data analyst (L2)
Read more
The Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) of the International AIDS Society launched a new round of research grants on 3 October 2022. If you are an early-stage investigator working on paediatric and adolescent HIV, you can apply to the CIPHER Grant Programme and become the principal investigator on a research project with a grant of up to US$150,000 over two years.
The new round of grants will focus primarily on HIV research in paediatric, adolescent and mental health. CIPHER aims to support research projects that could inform HIV policies and programmes, thus accelerating the HIV response in Grantees’ countries. There is now an opportunity to learn from, adapt and enhance the innovative approaches to paediatric and adolescent HIV that have been developed during the COVID-19 response.
Application to the CIPHER Grant Programme is a two-stage process.
Letter of Intent deadline = 31 October 2022
Full Proposal deadline for shortlisted candidates = 27 January 2023
Link:CIPHER Grant Programme 2022/2023
Also remember to submit your applications to the Pre-Award Office for budget review before submission to the funder.
Read more